3-40532818-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_198484.5(ZNF621):c.1048G>A(p.Val350Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000263 in 1,614,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_198484.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF621 | NM_198484.5 | c.1048G>A | p.Val350Ile | missense_variant | 5/5 | ENST00000339296.10 | NP_940886.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF621 | ENST00000339296.10 | c.1048G>A | p.Val350Ile | missense_variant | 5/5 | 1 | NM_198484.5 | ENSP00000340841 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152166Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000127 AC: 32AN: 251156Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135774
GnomAD4 exome AF: 0.000277 AC: 405AN: 1461868Hom.: 0 Cov.: 31 AF XY: 0.000260 AC XY: 189AN XY: 727232
GnomAD4 genome AF: 0.000125 AC: 19AN: 152166Hom.: 0 Cov.: 33 AF XY: 0.0000942 AC XY: 7AN XY: 74326
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2021 | The c.1048G>A (p.V350I) alteration is located in exon 5 (coding exon 4) of the ZNF621 gene. This alteration results from a G to A substitution at nucleotide position 1048, causing the valine (V) at amino acid position 350 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at